TRVN logo

Trevena (TRVN)

Profile

Full Name

Trevena, Inc.

Ticker Symbol

TRVN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 31, 2014

Indexes

Not included

Website

http://www.trevena.com

Employees

23

Key Details

Price

$1.10(+4.76%)

Market cap

$950.18K(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.13M(+847.61% YoY)

Annual EPS

-$79.00(+58.37% YoY)

PE ratio

-

Next earnings date

Jul 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.10
    TRVN price is $1.10

    30-Day Relative Volume

    2.19
    TRVN 30-day relative volume is 2.19

    Price Performance

    Price Most recent change

    +4.76%
    TRVN price was up +4.76% on Jul 2, 2025

    Price YTD change

    -26.67%
    TRVN price is down -26.67% since January 1st

    Price 1-year change

    -78.85%
    TRVN price is down -78.85% year-on-year

    Price 3-year change

    -99.55%
    TRVN price is down -99.55% over the past 3 years

    Price Range

    Price All-time high

    $8481.25
    TRVN price is currently -99.99% below its historical high of $8481.25

    Price 3-year low

    $0.72
    TRVN price is currently +51.72% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $950.18K
    TRVN market capitalization is $950.18 thousand

    Market cap 3-year change

    -98.53%
    TRVN market capitalization is down -98.53% over the past 3 years

    Market cap All-time high

    $655.69M
    TRVN market capitalization is currently -99.86% below its historical high of $655.69 million

    Market cap sector rank

    3.93%
    TRVN market capitalization is higher than 3.93% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.28%
    TRVN shares outstanding is up +1.28% year-on-year

    Shares Outstanding 3-Year Change

    +225.84%
    TRVN shares outstanding is up +225.84% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.93
    TRVN beta is 0.93

    200-day SMA

    $1.73
    TRVN price is currently -36.44% below its 200-day simple moving average

    50-day SMA

    $1.14
    TRVN price is currently -3.22% below its 50-day simple moving average

    RSI

    50.29
    TRVN 14-day relative strength index is 50.29

    Volume

    2.19
    TRVN 30-day relative volume is 2.19

    ATR

    $0.07
    TRVN average true range is $0.07

    10-day Historical Volatility

    57.08%
    TRVN 10-day historical volatility is 57.08%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $3.13M
    TRVN annual revenue is $3.13 million

    Revenue Analysts estimate

    $628.00K
    TRVN annual revenue is currently +397.61% higher than the consensus analysts' forecast

    Revenue 1-year change

    +847.61%
    TRVN annual revenue is up +847.61% year-on-year

    Revenue Sector rank

    17.97%
    TRVN annual revenue is higher than 17.97% of companies in Healthcare sector

    EPS

    EPS

    -$79.00
    TRVN annual earnings per share is -$79.00

    EPS Analysts estimate

    -$23.04
    TRVN annual earnings per share is currently +242.88% higher than the consensus analysts' forecast

    EPS 1-year change

    +58.37%
    TRVN annual earnings per share is up +58.37% year-on-year

    EPS Sector rank

    2.64%
    TRVN annual earnings per share is higher than 2.64% of companies in Healthcare sector

    Profit

    Gross profit

    $1.46M
    TRVN annual gross profit is $1.46 million

    Gross margin

    46.56%
    TRVN annual gross profit margin is 46.56%

    Operating profit

    -$35.29M
    TRVN annual operating income is -$35.29 million

    Operating margin

    -1129.22%
    TRVN annual operating profit margin is -1129.22%

    Net income

    -$40.29M
    TRVN annual net profit is -$40.29 million

    Net margin

    -1289.25%
    TRVN annual net profit margin is -1289.25%

    Expenses

    Total expenses

    $38.41M
    TRVN annual total expenses is $38.41 million

    Operating expenses

    $36.74M
    TRVN annual total operating expenses is $36.74 million

    Cost of goods sold

    $1.67M
    TRVN annual cost of goods sold is $1.67 million

    Selling, general & administrative expenses

    $20.41M
    TRVN annual SGA is $20.41 million

    Depreciation and amortization

    $334.00K
    TRVN annual depreciation & amortization is $334.00 thousand

    Interest expense

    $3.64M
    TRVN annual interest expense is $3.64 million

    Income tax

    $318.00K
    TRVN annual income tax is $318.00 thousand

    EBIT & EBITDA

    EBIT

    -$36.33M
    TRVN annual earnings before interest & taxes is -$36.33 million

    EBITDA

    -$35.99M
    TRVN annual EBITDA is -$35.99 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $40.60M
    TRVN annual total assets is $40.60 million

    Non current assets

    $5.40M
    TRVN annual long term assets is $5.40 million

    Current assets

    $35.20M
    TRVN annual total current assets is $35.20 million

    Cash and cash equivalents

    $32.98M
    TRVN annual cash & cash equivalents is $32.98 million

    Accounts receivable

    -
    TRVN annual accounts receivable value is unknown

    Inventory

    $0.00
    TRVN annual inventory is $0.00

    Liabilities

    Total liabilities

    $48.26M
    TRVN annual total liabilities is $48.26 million

    Long term liabilities

    $40.71M
    TRVN annual total long term liabilities is $40.71 million

    Current liabilities

    $7.55M
    TRVN annual total current liabilities is $7.55 million

    Accounts payable

    $2.30M
    TRVN annual accounts payable is $2.30 million

    Debt

    Total debt

    $36.24M
    TRVN annual total debt is $36.24 million

    Total debt 1-year change

    +83.38%
    TRVN annual total debt is up +83.38% year-on-year

    Long term debt

    $35.23M
    TRVN annual long term debt is $35.23 million

    Short term debt

    $1.01M
    TRVN annual short term debt is $1.01 million

    Equity & Capital

    Shareholders equity

    -$7.66M
    TRVN annual stockholders equity is -$7.66 million

    Book value

    -$7.66M
    TRVN annual book value is -$7.66 million

    Retained earnings

    -$588.06M
    TRVN annual retained earnings is -$588.06 million

    Working capital

    $27.65M
    TRVN annual working capital is $27.65 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$33.03M
    TRVN annual cash flow from operations is -$33.03 million

    Cash from operations 1-year change

    +35.83%
    TRVN annual cash flow from operations is up +35.83% year-on-year

    Cash from investing

    -$41.00K
    TRVN annual cash flow from investing activities is -$41.00 thousand

    Cash from investing 1-year change

    -327.78%
    TRVN annual cash flow from investing activities is down -327.78% year-on-year

    Cash from financing

    $26.31M
    TRVN annual cash flow from financing activities is $26.31 million

    Cash from financing 1-year change

    +11.94%
    TRVN annual cash flow from financing activities is up +11.94% year-on-year

    CAPEX

    CAPEX

    $41.00K
    TRVN annual capital expenditures is $41.00 thousand

    CAPEX 1-year change

    +46.43%
    TRVN annual capital expenditures is up +46.43% year-on-year

    Free Cash Flow

    Free cash flow

    -$33.08M
    TRVN annual free cash flow is -$33.08 million

    Free cash flow 1-year change

    +35.78%
    TRVN annual free cash flow is up +35.78% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    46.56%
    TRVN annual gross profit margin is 46.56%

    Operating margin

    -1129.22%
    TRVN annual operating profit margin is -1129.22%

    Net margin

    -1289.25%
    TRVN annual net profit margin is -1289.25%

    ROA & ROE

    ROA

    -90.25%
    TRVN annual return on assets is -90.25%

    ROE

    -1014.58%
    TRVN annual return on equity is -1014.58%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    TRVN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    TRVN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -0.04
    TRVN price to book ratio is -0.04

    PB ratio Sector rank

    14.09%
    TRVN price to book ratio is higher than 14.09% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.74
    TRVN price to sales ratio is 1.74

    PS ratio Sector rank

    37.04%
    TRVN price to sales ratio is higher than 37.04% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $25.05M
    TRVN enterprise value is $25.05 million

    Enterprise value Sector rank

    30.78%
    TRVN enterprise value is higher than 30.78% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.82
    TRVN EV/EBITDA is -0.82

    EV/EBITDA Sector rank

    50.09%
    TRVN EV/EBITDA is higher than 50.09% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.66
    TRVN annual current ratio is 4.66

    Quick ratio

    4.66
    TRVN annual quick ratio is 4.66

    Leverage

    Debt to equity

    -4.02
    TRVN annual debt to equity ratio is -4.02

    Interest coverage ratio

    -9.97
    TRVN annual interest coverage ratio is -9.97

    Risk & Stability

    Piotroski F-Score

    2
    TRVN piotroski f-score is 2

    Altman Z-Score

    -22.32
    TRVN altman z-score is -22.32

    Analyst ratings

    Recent major analysts updates

    Nov 14, 24 HC Wainwright & Co.
    Neutral
    May 16, 24 HC Wainwright & Co.
    Buy
    Apr 2, 24 HC Wainwright & Co.
    Buy
    Mar 11, 24 HC Wainwright & Co.
    Buy
    May 17, 23 JMP Securities
    Market Outperform
    Mar 31, 23 JMP Securities
    Market Outperform
    Mar 31, 23 HC Wainwright & Co.
    Buy
    May 12, 22 HC Wainwright & Co.
    Buy
    Mar 15, 21 Oppenheimer
    Perform
    Sep 14, 20 Guggenheim
    Buy

    Institutional Ownership

    Screeners with TRVN included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotechnology industry
    • What is the ticker symbol for Trevena?
    • Does Trevena pay dividends?
    • What sector is Trevena in?
    • What industry is Trevena in?
    • What country is Trevena based in?
    • When did Trevena go public?
    • Is Trevena in the S&P 500?
    • Is Trevena in the NASDAQ 100?
    • Is Trevena in the Dow Jones?
    • When was Trevena's last earnings report?
    • When does Trevena report earnings?
    • Should I buy Trevena stock now?

    What is the ticker symbol for Trevena?

    The ticker symbol for Trevena is NASDAQ:TRVN

    Does Trevena pay dividends?

    No, Trevena does not pay dividends

    What sector is Trevena in?

    Trevena is in the Healthcare sector

    What industry is Trevena in?

    Trevena is in the Biotechnology industry

    What country is Trevena based in?

    Trevena is headquartered in United States

    When did Trevena go public?

    Trevena's initial public offering (IPO) was on January 31, 2014

    Is Trevena in the S&P 500?

    No, Trevena is not included in the S&P 500 index

    Is Trevena in the NASDAQ 100?

    No, Trevena is not included in the NASDAQ 100 index

    Is Trevena in the Dow Jones?

    No, Trevena is not included in the Dow Jones index

    When was Trevena's last earnings report?

    Trevena's most recent earnings report was on Nov 7, 2024

    When does Trevena report earnings?

    The next expected earnings date for Trevena is Jul 15, 2025

    Should I buy Trevena stock now?

    As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page